ArTara Therapeutics, Inc. announces that the company's research and development pipeline is progressing smoothly, and key clinical trials are advancing according to the established schedule.
Show original
It is currently expected that in the second half of 2026, the Advanced-3 phase registration clinical trial for BCG treatment-naïve patient groups will be officially launched. The initiation of this trial is an important milestone in the company's drug development pathway, marking another key step forward for its core candidate product towards potential approval and market launch.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
The US Dollar Index rose to 97.844, and the euro depreciated to 1.1779 US dollars.
Chaincatcher•2026/02/24 20:35
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$64,453
+0.01%
Ethereum
ETH
$1,857.75
-0.12%
Tether USDt
USDT
$1
+0.03%
XRP
XRP
$1.36
+0.17%
BNB
BNB
$588.51
-1.08%
USDC
USDC
$1
+0.01%
Solana
SOL
$78.69
+0.38%
TRON
TRX
$0.2832
+0.72%
Dogecoin
DOGE
$0.09223
-1.15%
Bitcoin Cash
BCH
$482.71
-2.42%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now